Gentamicin
2 results
Applied filters
Gentamicin: informing intrathecal risk assessment
29 October 2025Gentamicin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Implementing pharmacogenomic testing for aminoglycosides
10 June 2025Patients with mitochondrial variants have an increased risk of deafness with amikacin, gentamicin, neomycin and tobramycin. Guidance on testing is provided.